Search results
New COVID-19 FLiRT variants are now the dominant variant. Could there be a summer surge?
USA TODAY via Yahoo News· 5 hours agoAccording to the CDC, only 22.6% of adults reported having received an updated 2023-24 COVID-19 vaccine since September 2023. Data also ...
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
Motley Fool via Yahoo Finance· 12 minutes agoA big name in COVID-19 care Much of Novavax's name recognition comes from the thick of the COVID-19...
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 9 hours agoLet's find out. Image source: Getty Images. Novavax falls behind First, a quick summary of Novavax's story so far. The vaccine maker's shares soared...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize ...
Benzinga· 6 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID ...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 1 day agoHere's a look at Novavax's deal with Sanofi to see if buying this stock now could be a smart move....
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19
COVID-19 deaths increase to 4 in N.B., hospitalizations drop to 3, fewer than flu admissions
CBC via Yahoo News· 1 day agoCOVID-19 deaths in New Brunswick doubled to four, week-over-week, while hospitalizations for or with...
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
Motley Fool via Yahoo Finance· 7 hours agoNovavax: Call it a comeback Last Friday, Novavax announced a co-exclusive licensing agreement with...
Meghan Markle and Prince Harry's foundation ordered to stop fundraising: What to know
Yahoo Celebrity· 1 day agoCalifornia’s attorney general, Rob Bonta, sent a letter to the couple’s foundation stating it’s...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 2 days agoEarlier this month, along with its earnings release, Moderna reiterated its product revenue guidance...